Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00630292 · ClinicalTrials.gov registry record · NA
Feasibility Study of Vessel Analysis for Noninvasive Diagnosis of Malignancy in Breast Tumors
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT00630292 is a NA study that was terminated before completion, run by University of North Carolina, Chapel Hill. The registered enrollment target is 6 participants.
The verdict
NCT00630292, a NA study, was terminated before completion, sponsored by University of North Carolina, Chapel Hill.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This is a pilot study designed to explore the feasibility of non-invasively diagnosing the presence of cancer in the breast using non-invasive magnetic resonance imaging (MRI) methods and an analysis of vessel shape defined from these magnetic resonance images.
Interventions
- OTHER Magnetic Resonance Angiography (MRA) of the Breast
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-03 |
| Est. Completion | 2009-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00630292
The ClinicalTrials.gov registry entry for NCT00630292 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Magnetic Resonance Angiography (MRA) of the Breast is the first listed.
NCT00630292 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00630292 about?
NCT00630292 is a clinical study titled "Feasibility Study of Vessel Analysis for Noninvasive Diagnosis of Malignancy in Breast Tumors". This is a pilot study designed to explore the feasibility of non-invasively diagnosing the presence of cancer in the breast using non-invasive magnetic resonance imaging (MRI) methods and an analysis of vessel shape defined from these magnetic resonance images.
What is the current status of trial NCT00630292?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2008-03. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00630292?
The interventions under investigation include: Magnetic Resonance Angiography (MRA) of the Breast (OTHER).
Who is sponsoring clinical trial NCT00630292?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.